| dc.contributor.author | Casey, L | en_US |
| dc.contributor.author | Powell, A | en_US |
| dc.contributor.author | Bohm, S | en_US |
| dc.contributor.author | Manchanda, R | en_US |
| dc.contributor.author | Lockley, M | en_US |
| dc.contributor.author | Kobel, M | en_US |
| dc.contributor.author | Singh, N | en_US |
| dc.date.accessioned | 2020-11-25T11:54:00Z | |
| dc.date.issued | 2020 | en_US |
| dc.identifier.issn | 0023-6837 | en_US |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/68676 | |
| dc.format.extent | 1024 - 1024 | en_US |
| dc.title | Role of Ki67 Proliferation Index and CD8 Tumour-Infitrating Lymphocyte Counts in Predicting Outcome in High-Grade Serous Tubo-Ovarian Carcinoma (HGSC) Showing No/Partial Response to Neoadjuvant Chemotherapy | en_US |
| dc.type | Conference Proceeding | |
| pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000518328802210&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | SUPPL 1 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 100 | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
| qmul.funder | Discovering new therapies for chemotherapy resistant high grade serous ovarian cancer::Barts and The London Charity | en_US |
